SCHEMBL7944004

SCHEMBL7944004

COc1ccc(Cl)cc1-c1n[nH]c(=O)n1Cc1ccc(C(F)(F)F)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPGD P15428 3/20 0.49
KMT2A Q03164 2/20 0.49
LMNA P02545 2/20 0.49
MEN1 O00255 1/20 0.49
PPARG P37231 1/20 0.49
NCOA2 Q15596 1/20 0.49
NCOA1 Q15788 1/20 0.49
APOBEC3G Q9HC16 1/20 0.49
KDM4E B2RXH2 1/20 0.49
ALDH1A1 P00352 1/20 0.49
TSHR P16473 1/20 0.49
CYP2C9 P11712 1/20 0.43
P2RX3 P56373 2/20 0.43
GAA P10253 1/20 0.41
MAPT P10636 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
GFER P55789 1/20 0.41
DRD4 P21917 1/20 0.41
NPBWR1 P48145 1/20 0.40
KCNQ3 O43525 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5753004 0.84 ALDH1A1 (0.45) HPGDKMT2AMEN1ALDH1A1CYP2C9
SCHEMBL7950922 0.83 CYP2C9 (0.47) HPGDKMT2ALMNAMEN1PPARG
SCHEMBL7952036 0.74 SMN1; SMN2 (0.47) HPGDKMT2ALMNAKDM4EALDH1A1
SCHEMBL7944037 0.74 LMNA (0.39) HPGDKMT2ALMNAMEN1APOBEC3G
SCHEMBL2435199 0.70 GAA (0.64) HPGDKMT2ALMNAMEN1APOBEC3G
SCHEMBL5757289 0.70 SMN1; SMN2 (0.47) HPGDKMT2ALMNAMEN1KDM4E
SCHEMBL7957104 0.70 ATM (0.46) TSHRCYP2C9NPBWR1KCNQ3KCNQ2
SCHEMBL7954633 0.69 NR1I2 (0.47) HPGDKMT2AMEN1CYP2C9SMN1; SMN2
SCHEMBL5755396 0.68 CYP1A2 (0.50) HPGDLMNAKDM4EALDH1A1CYP2C9
SCHEMBL8233143 0.67 ALDH1A1 (0.58) HPGDKMT2ALMNAMEN1APOBEC3G

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6271249-B1 Diphenyl imidazoles as potassium channel modulators BRISTOL-MYERS SQUIBB COMPANY 2001-08-07 US disclosed
US-6077861-A MODULATORS OF THE LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM (BK) CHANNELS, THEREFORE, USEFUL IN THE TREATMENT OF ISCHEMIC STROKE BRISTOL-MYERS SQUIBB COMPANY (US) 2000-06-20 US disclosed
US-5869509-A TREAT DISORDERS RESPONSIVE TO OPENERS OF THE LARGE CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-02-09 US disclosed